Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Tacrolimus

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44338   clinical trials with a EudraCT protocol, of which   7368   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    440 result(s) found for: Tacrolimus. Displaying page 4 of 22.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2004-000304-41 Sponsor Protocol Number: FG-506E-12-03 Start Date*: 2004-12-15
    Sponsor Name:Astellas Pharma GmbH
    Full Title: A MULTICENTRE, 1:1 RANDOMISED, DOUBLE BLIND, TWO ARM PARALLEL GROUP STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF MODIFIED RELEASE TACROLIMUS FK506E (MR4) VERSUS TACROLIMUS FK506 IN COMB...
    Medical condition: Patients with end stage kidney disease who will undergo renal transplantation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10014646 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: CZ (Completed) SE (Completed) HU (Completed) FI (Completed) AT (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-003240-11 Sponsor Protocol Number: LCP-Tacro 3001 Start Date*: 2009-02-25
    Sponsor Name:LifeCycle Pharma A/S
    Full Title: A Phase 3, Open-label, Multicenter, Prospective, Randomized Study of the Efficacy and Safety of Conversion from Prograf® Capsules Twice Daily to LCP-Tacro™ Tablets Once Daily for the Prevention of ...
    Medical condition: LCP-Tacro tablets will be investigated for immunosuppression for the prevention of acute allograft rejection in adult renal transplant patients.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10048870 Prophylaxis against transplant rejection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) ES (Completed) GB (Completed) FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-000784-33 Sponsor Protocol Number: TacTremorConversion Start Date*: 2017-07-31
    Sponsor Name:Fundació Clínic per a la Recerca Biomèdica
    Full Title: Effect of Envarsus conversion on tacrolimus-associated tremor in renal transplant patients. An open-label, single centre, prospective pharmacodynamic/pharmacokinetic clinical study
    Medical condition: Tacrolimus-associated tremor
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029205 - Nervous system disorders 10044565 Tremor PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-005572-28 Sponsor Protocol Number: CCD-06235AA1-02 Start Date*: 2015-05-11
    Sponsor Name:Chiesi Farmaceutici S.p.A.
    Full Title: Open-label, Multicentre, Randomized Clinical Trial To Compare The Pharmacokinetics Of Envarsus® Tablets And Advagraf® Capsules Administered Once Daily In Adult De-novo Kidney Transplant Patients
    Medical condition: Immunosuppression in adult de-novo kidney transplant
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004865 10050436 Prophylaxis against renal transplant rejection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2009-017843-32 Sponsor Protocol Number: LOL-III-1 Start Date*: 2010-10-14
    Sponsor Name:Foundation of Liver Research (SLO)
    Full Title: A multi-center randomized, open label, controlled study in primary liver transplantation comparing long term renal function and development of de novo malignancy in recipients treated with standard...
    Medical condition: Liver transplantation
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004865 10050434 Prophylaxis against liver transplant rejection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-004538-14 Sponsor Protocol Number: TACTOR-2013 Start Date*: 2014-07-30
    Sponsor Name:Azienda Ospedaliera Universitaria Integrata Verona
    Full Title: Identification of a specific systemic transcriptome able to differentiate patients with renal transplantation in chronic treatment with tacrolimus from those with mTOR inhibitors.
    Medical condition: Renal Transplantation
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-001191-38 Sponsor Protocol Number: CRAD001HES01 Start Date*: 2013-08-21
    Sponsor Name:Novartis Farmacéutica, S.A.
    Full Title: Multicentric, randomized, open-label, controlled study, of 12 months of follow-up to assess the effect in renal function of a immunosuppressive treatment based on tacrolimus minimization in combin...
    Medical condition: Asumiendo una mayor eficacia en la prevención del rechazo agudo en el brazo de everolimus con minimización de los niveles de tacrolimus, la hipótesis del presente ensayo es que la introducción de e...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-002078-45 Sponsor Protocol Number: FG-506-17-05 Start Date*: 2004-11-01
    Sponsor Name:Fujisawa GmbH
    Full Title: A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TACROLIMUS MDI AS ADD-ON THERAPY TO ICS AND LABA IN MODERATE TO SEVERE PERSISTENT ASTHMATIC PATIENTS
    Medical condition: Asthma
    Disease: Version SOC Term Classification Code Term Level
    7.0 10003553 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed) HU (Completed)
    Trial results: View results
    EudraCT Number: 2010-020925-42 Sponsor Protocol Number: PMR-EC-1206 Start Date*: 2011-01-27
    Sponsor Name:Astellas Pharma Europe Ltd.
    Full Title: A Phase II, Open-Label, Multi-Center Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted from a Prograf® Based Immunosuppressive Regimen to a Tacr...
    Medical condition: Prophylaxis of primary liver, kidney, heart, lung, and intestinal organ transplant rejection
    Disease: Version SOC Term Classification Code Term Level
    12.1 10052062 Prophylaxis against intestinal transplant rejection LLT
    12.1 10050432 Prophylaxis against heart transplant rejection LLT
    12.1 10050433 Prophylaxis against lung transplant rejection LLT
    12.1 10050434 Prophylaxis against liver transplant rejection LLT
    12.1 10050436 Prophylaxis against renal transplant rejection LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: AT (Completed) FR (Completed) DE (Completed) BE (Completed) PL (Completed) CZ (Trial now transitioned) IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-001265-41 Sponsor Protocol Number: 200621 Start Date*: 2006-06-16
    Sponsor Name:Newcastle upon Tyne Hospitals NHS Trust
    Full Title: A comparison of Sirolimus versus Tacrolimus as a delayed treatment of recipients of non heart beating donor kidneys after anti-IL2 monoclonal antibody
    Medical condition: Kidney transplantation from non heart beating donors for end-stage renal disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-004052-39 Sponsor Protocol Number: BKR-AD-04 Start Date*: 2005-01-05
    Sponsor Name:BørneklinikkenRanders
    Full Title: Korttidsvækst hos børn med atopisk dermatitis behandlet med tacrolimus og hydrokortison-17-butyrat
    Medical condition: Atopisk dermatitis
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-000012-27 Sponsor Protocol Number: / Start Date*: 2005-09-06
    Sponsor Name:Department of Nephrology and Renal Transplantation
    Full Title: Pharmacokinetic interactions between probenecid and the combination mycophenolate mofetil - cyclosporine/tacrolimus in stable renal allograft recipients
    Medical condition: Renal transplant recipients treated with mycophenolate mofetil and tacrolimus.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2008-003189-25 Sponsor Protocol Number: ASSTRO Start Date*: 2011-03-29
    Sponsor Name:ASOCIACION PARA LA INVESTIGACION Y TRATAMIENTO DE ENFERMEDADES RENALES (AITER),
    Full Title: ensayo multicéntrico, aleatorizado, abierto que compara la eficacia y seguridad de un régimen inmunosupresor basado en basiliximab, introducción inmediata de dosis reducidas de tacrolimus de libera...
    Medical condition: En casos de trasplantes renales en pacientes añosos, los injertos tienen una incidencia mayor de necrosis tubular aguda, y mayor sensibilidad a los efectos de las drogas nefrotóxicas, implicando un...
    Disease: Version SOC Term Classification Code Term Level
    11 10038533 Trasplante renal LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-000936-28 Sponsor Protocol Number: PMR-EC-1105 Start Date*: 2006-09-14
    Sponsor Name:Astellas Pharma Europe Limited
    Full Title: A MULTICENTER, OPEN, SINGLE SEQUENCE CROSSOVER STUDY TO ASSESS THE SAFETY AND EFFICACY OF A TACROLIMUS MODIFIED RELEASE, FK506E (MR4), BASED IMMUNOSUPPRESSIVE REGIMEN IN STABLE LIVER TRANSPLANT PAT...
    Medical condition: Stable, adult liver transplant recipients (≥ 12 months post transplant) who are currently treated with Prograf.
    Disease: Version SOC Term Classification Code Term Level
    7.0 10024716 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) IE (Completed) ES (Completed) FR (Completed) CZ (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-005635-10 Sponsor Protocol Number: ATEGE_LIVER Start Date*: 2006-05-22
    Sponsor Name:Liver Unit, ICMD, Hospital Clinic Barcelona
    Full Title: INDUCTION TREATMENT FOLLOWED BY IMMUNOSUPPRESSION WITHDRAWAL IN LIVER TRANSPLANTATION: A COMPARATIVE TRIAL. Tratamiento de inducción y retirada de la inmunosupresión en el trasplante hepático. Estu...
    Medical condition: Liver transplantation
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-004441-42 Sponsor Protocol Number: UK-06-RG-63 Start Date*: 2007-03-01
    Sponsor Name:Southport and Ormskirk Hospital NHS Trust
    Full Title: A study to evaluate the role of tacrolimus ointment (Protopic®) 0.1% in the treatment of chronic otitis externa.
    Medical condition: Chronic Otitis Externa
    Disease: Version SOC Term Classification Code Term Level
    8.1 10031744 Other chronic otitis externa LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2017-000718-52 Sponsor Protocol Number: DMPT-17 Start Date*: 2017-05-09
    Sponsor Name:Hospital Universitario de Canarias
    Full Title: Efficacy of a new formulation of a daily lctp dose of tacrolimus (ENVARSUS®) to prevent diabetes post renal transplant in patients at risk: a controlled randomized open pilot study
    Medical condition: diabetes post-renal trasnplant
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: View results
    EudraCT Number: 2004-002924-16 Sponsor Protocol Number: FG-506-01-IT-02 Start Date*: 2004-10-22
    Sponsor Name:FUJISAWA
    Full Title: AN OPEN, MULTICENTRE, RANDOMISED PARALLEL GROUP CLINICAL STUDY TO COMPARE SAFETY AND EFFICACY OF TACROLIMUS FK506 WITH MONOCLONAL ANTI-IL2R ANTIBODIES DACLIZUMAB VS TACROLIMUS FK506 WITH STER...
    Medical condition: PREVENTION OF REJECTION OF SUBOPTIMAL LIVERS IN LIVER ALLOGRAFT RECIPIENTS. COMPARE SAFETY AND EFFICACY OF TACROLIMUS FK506 WITH MONOCLONAL ANTI-IL2R ANTIBODIES DACLIZUMAB VS TACROLIMUS FK506 ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10019654 Hepatic and hepatobiliary disorders HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2015-003288-12 Sponsor Protocol Number: 02-0-158 Start Date*: 2015-08-05
    Sponsor Name:Fujisawa Healthcare, Inc.
    Full Title: A Phase III, Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf® (tacrolimus)/MMF, Modified Release (MR) Tacrolimus /MMF and Neoral®(cyclosporin...
    Medical condition: Kidney transplant recipients
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004865 10050436 Prophylaxis against renal transplant rejection LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2010-019574-33 Sponsor Protocol Number: BRD 09/7-D Start Date*: 2010-08-27
    Sponsor Name:CHU de Nantes
    Full Title: Etude prospective, multicentrique, randomisée, en double-aveugle, contrôlée à groupes parallèles, visant à évaluer la balance bénéfice-risque du sevrage progressif d'un inhibiteur de la calcineurin...
    Medical condition: Transplantation rénale
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 23 07:46:43 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA